Meet Resyca at CPHI 2026 and discover how our customisable soft mist inhalation platforms and complete end-to end services can make your journey to market seamless.

At Resyca, we specialise in propellant-free soft mist inhalation and nasal spray devices designed for liquid formulations. Engineered for high delivery efficiency and patient-centric ease of delivery, our platforms are ready to bring your breakthroughs to market, quickly and sustainably. 

Find us at CPHI to:

• Learn how our platforms are designed for next-generation biologics, and can be tailored to your molecule. 

Discover how we can support you from concept and formulation, through to scaling and commercial launch.

Explore how our specialist interdisciplinary team and legacy of expertise make navigating the rapidly-evolving regulatory landscape a breeze.

Book a meeting now to start your journey to market with confidence.